HealthcareServices

Narcolepsy Market Forecast 2026–2035: How to Leverage Market Growth

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the narcolepsy market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Narcolepsy Market’s size between 2026 and 2030?

The narcolepsy market size has seen rapid expansion in recent years. It is anticipated to increase from $3.95 billion in 2025 to $4.38 billion in 2026, at a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to factors such as limited awareness of narcolepsy, delayed diagnosis rates, the widespread reliance on stimulant medications, the introduction of sodium oxybate, and an increase in sleep disorder research.

The narcolepsy market is projected to experience substantial growth in the upcoming years, expanding to $6.62 billion by 2030, at a compound annual growth rate (CAGR) of 10.9%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing prevalence of sleep disorders, heightened investment in research and development, an expanding pipeline of non-stimulant therapies, more robust patient education initiatives, and breakthroughs in precision medicine approaches. Key trends observed within this timeframe include a heightened awareness and improved diagnosis of narcolepsy, a greater uptake of combination therapy, a rising need for long-acting treatments, the broadening availability of non-stimulant treatment choices, and a more concentrated effort on therapeutics specifically targeting cataplexy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16491&type=smp

Which Drivers Are Shaping Strategic Decisions In The Narcolepsy Market?

An increasing population affected by obesity is anticipated to stimulate the expansion of the narcolepsy market in the future. Obesity is a medical condition characterized by an excessive accumulation of body fat, which poses a health risk. The rise in obese individuals stems from increasingly inactive routines, inadequate eating patterns, and environmental influences that encourage high-calorie food intake while limiting physical exertion. By disturbing metabolic and hormonal equilibrium, obesity has the potential to contribute to narcolepsy, possibly resulting in altered sleep cycles and wakefulness control. For example, in May 2025, the Office for Health Improvement & Disparities, a government department in the UK, reported that approximately 64.5 percent of adults aged 18 and over in England were overweight or living with obesity during 2023–2024. This figure marked an increase from 64.0 percent recorded in 2022–2023, signifying an ongoing upward progression. Consequently, the expanding population of obese individuals is propelling the advancement of the narcolepsy market.

What Segment Classifications Make Up The Narcolepsy Market?

The narcolepsy market covered in this report is segmented –

1) By Type: Type 1, Type 2

2) By Treatment: Antidepressants, Stimulants, Sodium Oxybate, Other Treatments

3) By Diagnosis: Polysomnogram, Multiple Sleep Latency Test

Subsegments:

1) By Type 1: Stimulant Medications, Antidepressants, Sodium Oxybate, Immunosuppressive Treatments

2) By Type 2: Stimulant Medications, Sodium Oxybate, Antidepressants

What Trends Are Projected To Support The Growth Of The Narcolepsy Market?

Leading companies within the narcolepsy market are intensifying their efforts to create innovative drugs, such as extended-release sodium oxybate, to satisfy the increasing need for effective treatments. Extended-release sodium oxybate is a medicine employed in narcolepsy therapy. This extended-release formulation enables the medication to be released controllably over an extended duration, providing continuous symptom relief throughout the night and enhancing sleep quality for individuals experiencing narcolepsy. For instance, in June 2023, Avadel Pharmaceuticals plc, an Ireland-based pharmaceutical company, introduced LUMRYZ in the United States. LUMRYZ represents an extended-release variant of sodium oxybate, which received FDA approval for managing cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. It stands as the initial and sole once-at-bedtime oxybate treatment for narcolepsy, offering a significant advantage over existing twice-nightly oxybate products by eliminating the requirement to awaken for a second dose at night.

Which Major Firms Are Strengthening Their Position In The Narcolepsy Market?

Major companies operating in the narcolepsy market are Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Alkermes, Harmony Biosciences, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Bioprojet Pharma, Centessa Pharmaceuticals, Hikma Pharmaceuticals, Theranexus SA, Eisai Co Ltd, Ligand Pharmaceuticals, Graymark Healthcare Inc, H Lundbeck A/S

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Narcolepsy Market?

North America was the largest region in the narcolepsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Narcolepsy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16491&type=smp

Browse Through More Reports Similar to the Global Narcolepsy Market 2026, By The Business Research Company

Catalepsy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/catalepsy-treatment-global-market-report

Narcolepsy Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/narcolepsy-drugs-global-market-report

Narcotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795